Lyrica adds third indication
Executive Summary
Pfizer's Lyrica (pregabalin) clears FDA June 10 for treatment of partial onset seizures. The Neurontin follow-on was approved for diabetic peripheral neuropathy and postherpetic neuralgia in December 2004 (1"The Pink Sheet" Jan. 10, 2005, p. 5). Lyrica's launch is awaiting final Drug Enforcement Agency scheduling. Pfizer says pregabalin will be available in pharmacies in the fall...
Pfizer's Lyrica (pregabalin) clears FDA June 10 for treatment of partial onset seizures. The Neurontin follow-on was approved for diabetic peripheral neuropathy and postherpetic neuralgia in December 2004 (1 (Also see "Pfizer Lyrica Launch Awaits Controlled Substance Scheduling" - Pink Sheet, 10 Jan, 2005.), p. 5). Lyrica's launch is awaiting final Drug Enforcement Agency scheduling. Pfizer says pregabalin will be available in pharmacies in the fall.... |